{"symbol": "IMRN", "companyName": "Immuron Limited", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.immuron.com", "description": "Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.", "CEO": "Jerry Kanellos", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}